Chunghwa Chemical Synthesis & Biotech Co., Ltd.

TWSE:1762 Voorraadrapport

Marktkapitalisatie: NT$3.3b

Chunghwa Chemical Synthesis & Biotech Beheer

Beheer criteriumcontroles 2/4

De CEO Chunghwa Chemical Synthesis & Biotech is Chung-Hsin Huang, benoemd in Apr2018, heeft een ambtstermijn van 6.58 jaar. bezit rechtstreeks 0.074% van de aandelen van het bedrijf, ter waarde NT$ 2.44M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.6 jaar en 4.8 jaar.

Belangrijke informatie

Chung-Hsin Huang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO6.6yrs
Eigendom CEO0.07%
Management gemiddelde ambtstermijn6.6yrs
Gemiddelde ambtstermijn bestuur4.8yrs

Recente managementupdates

Recent updates

Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TWSE:1762) Business And Shares Still Trailing The Industry

Aug 09
Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TWSE:1762) Business And Shares Still Trailing The Industry

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80

Jul 12
Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Apr 01
A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 04
Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend

Jan 28
What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend

Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?

Jan 02
Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?

The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It

Dec 06
The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It

CEO

Chung-Hsin Huang

6.6yrs

Tenure

Mr. Chung-Hsin Huang serves as President & General Manager at Chunghwa Chemical Synthesis & Biotech Co., Ltd. Since April 1, 2018 and served as Director until May 2022. Mr. Huang had been Vice President of...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Chung-Hsin Huang
President & GM6.6yrsgeen gegevens0.074%
NT$ 2.4m
Kuan-Chieh Wang
Manager of Finance Department & Head of Corporate Governance6yrsgeen gegevensgeen gegevens
Jun-Jie Liao
Manager of Human Resource Office6.8yrsgeen gegevensgeen gegevens
Chao-Sheng Hong
Chief Auditorno datageen gegevensgeen gegevens

6.6yrs

Gemiddelde duur

Ervaren management: Het managementteam van 1762 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.6 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Kuo-Chiang Wang
Independent Director14.4yrsgeen gegevensgeen gegevens
Chih-Hsien Chang
Independent Director8.5yrsgeen gegevensgeen gegevens
Hou-Jie Wang
Director4.8yrsgeen gegevens1.3%
NT$ 42.5m
Yi-Zhen Xie Wang
Chairman of the Board4yrsgeen gegevens3.17%
NT$ 103.8m
Hou-Kai Wang
Vice-Chairmanless than a yeargeen gegevensgeen gegevens

4.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 1762 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).